These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1167 related articles for article (PubMed ID: 22678511)

  • 1. Kynurenines in the mammalian brain: when physiology meets pathology.
    Schwarcz R; Bruno JP; Muchowski PJ; Wu HQ
    Nat Rev Neurosci; 2012 Jul; 13(7):465-77. PubMed ID: 22678511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kynurenine pathway and the brain: Challenges, controversies and promises.
    Schwarcz R; Stone TW
    Neuropharmacology; 2017 Jan; 112(Pt B):237-247. PubMed ID: 27511838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.
    Török N; Majláth Z; Fülöp F; Toldi J; Vécsei L
    Curr Drug Metab; 2016; 17(5):412-29. PubMed ID: 26694727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine metabolites of tryptophan: implications for neurologic diseases.
    Freese A; Swartz KJ; During MJ; Martin JB
    Neurology; 1990 Apr; 40(4):691-5. PubMed ID: 2181342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
    Shilov IuE; Bezrukov MV
    Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics?
    Davis I; Liu A
    Expert Rev Neurother; 2015; 15(7):719-21. PubMed ID: 26004930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites.
    Moroni F
    Eur J Pharmacol; 1999 Jun; 375(1-3):87-100. PubMed ID: 10443567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities.
    Pocivavsek A; Schwarcz R; Erhardt S
    Pharmacol Rev; 2024 Oct; 76(6):978-1008. PubMed ID: 39304346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.
    Schwarcz R; Pellicciari R
    J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kynurenine and its metabolites in nervous system diseases].
    Vécsei L; Schwab F
    Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine Pathway in Diabetes Mellitus-Novel Pharmacological Target?
    Kozieł K; Urbanska EM
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine pathway metabolites in humans: disease and healthy States.
    Chen Y; Guillemin GJ
    Int J Tryptophan Res; 2009; 2():1-19. PubMed ID: 22084578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids: Glutamatergic Transmission and Kynurenines.
    Colín-González AL; Aguilera G; Santamaría A
    Adv Neurobiol; 2016; 12():173-98. PubMed ID: 27651254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan metabolism in the central nervous system: medical implications.
    Ruddick JP; Evans AK; Nutt DJ; Lightman SL; Rook GA; Lowry CA
    Expert Rev Mol Med; 2006 Aug; 8(20):1-27. PubMed ID: 16942634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.
    Erhardt S; Olsson SK; Engberg G
    CNS Drugs; 2009; 23(2):91-101. PubMed ID: 19173370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenines, Neuronal Excitotoxicity, and Mitochondrial Oxidative Stress: Role of the Intestinal Flora.
    Nagy-Grócz G; Spekker E; Vécsei L
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.